Improvement? Switched from Fin to Dut 3 months ago.
    Is this regrowth? 1/27/2025

    From the encyclopedia
    Finasteride β†’

    Frontline, gold standard treatment for combatting androgenic alopecia

    Dutasteride β†’

    Heavy duty finasteride that comes with higher risks

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    πŸ’Š Finasteride (oral) 2.5 mg ED 2 years
    πŸ’Š Dutasteride (oral) 0.5 mg ED 3 months
    the tone is πŸ˜€ positive with noticeable hair regrowth results.

    Other terms

    The user switched from finasteride to dutasteride three months ago and experienced noticeable hair regrowth without side effects. They did not use minoxidil and made the switch to dutasteride abruptly.
    View this post in the Community β†’

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results
      Finasteride in Androgenetic Alopecia in Men

      research Finasteride in androgenetic alopecia in men

      June 2007 in “Advances in Dermatology and Allergology/PostΔ™py Dermatologii i Alergologii”
      This article discusses androgenetic alopecia in men and reports that finasteride at 1 mg/day for 24 months is generally well tolerated and may effectively inhibit hair loss.
      Female Pattern Alopecia: Current Perspectives

      research Female pattern alopecia: current perspectives

      42 citations , August 2013 in “International Journal of Women's Health”
      This review discusses the current therapeutic options for female pattern hair loss and emphasizes the need for managing patient expectations of permanent regrowth, reporting no new clinical results.
      Androgens and Hair Loss: An In-Depth Analysis of Androgenetic Alopecia

      research Androgens and hair loss

      52 citations , June 2009 in “Current Opinion in Endocrinology, Diabetes and Obesity”
      This review discusses the pathogenesis and treatment of androgenetic alopecia, highlighting genome associations and newer topical formulations, but reports no new clinical results.
      Nonsurgical Therapy for Hair Loss

      research Nonsurgical Therapy for Hair Loss

      14 citations , August 2013 in “Facial Plastic Surgery Clinics of North America”
      This review discusses current and emerging medical therapies for androgenetic alopecia but reports no new clinical findings, emphasizing the importance of stabilizing the condition as a complement to surgical hair restoration.
      Safety Concerns When Using Novel Medications to Treat Alopecia

      research Safety concerns when using novel medications to treat alopecia

      23 citations , October 2018 in “Expert Opinion on Drug Safety”
      This review discusses the safety concerns associated with new treatments for non-scarring alopecias, highlighting that while these therapies such as JAK inhibitors and oral minoxidil show efficacy in hair regrowth, their safety profiles vary significantly, requiring careful consideration of benefits and risks.